BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29428906)

  • 1. Structural characteristics of natural chimeric genes and their implications for gene design.
    Li YX; Zhang TT; Ma L
    Yi Chuan; 2018 Feb; 40(2):135-144. PubMed ID: 29428906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromosomal rearrangements breakpoints clusterization: is the clonal selection involved].
    Umanskaia ON; Bystritskiĭ AA; Razin SV
    Mol Biol (Mosk); 2005; 39(3):355-63. PubMed ID: 15981564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting tropomyosin-receptor kinase fused gene in cancer.
    Chen Y; Tseng SH
    Anticancer Res; 2014 Apr; 34(4):1595-600. PubMed ID: 24692687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.
    Qin H; Malek S; Cowell JK; Ren M
    Oncogene; 2016 Oct; 35(43):5686-5691. PubMed ID: 27065320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EWS-WT1 gene fusion in desmoplastic small round cell tumor.
    Gerald WL; Haber DA
    Semin Cancer Biol; 2005 Jun; 15(3):197-205. PubMed ID: 15826834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of chromosomal alterations in human cancer development.
    Gasparini P; Sozzi G; Pierotti MA
    J Cell Biochem; 2007 Oct; 102(2):320-31. PubMed ID: 17722107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fusion genes and transcripts in neoplasia].
    Kekeeva TV; Zavalishina LÉ; Frank GA; Zaletaev DV
    Mol Biol (Mosk); 2011; 45(5):793-804. PubMed ID: 22393775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Structural Characterization of Tumor Fusion Genes and Proteins.
    Wang D; Li D; Qin G; Zhang W; Ouyang J; Zhang M; Xie L
    Comput Math Methods Med; 2015; 2015():912742. PubMed ID: 26347798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective destruction of tumor cells through specific inhibition of products resulting from chromosomal translocations.
    Rodriguez-García A; Sánchez-Martín M; Pérez-Losada J; Pérez-Mancera PA; Sagrera-Aparisi A; Gutiérrez-Cianca N; Cobaleda C; Sánchez-García I
    Curr Cancer Drug Targets; 2001 Aug; 1(2):109-19. PubMed ID: 12188884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages.
    Lannon CL; Sorensen PH
    Semin Cancer Biol; 2005 Jun; 15(3):215-23. PubMed ID: 15826836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations.
    Guarnerio J; Bezzi M; Jeong JC; Paffenholz SV; Berry K; Naldini MM; Lo-Coco F; Tay Y; Beck AH; Pandolfi PP
    Cell; 2016 Apr; 165(2):289-302. PubMed ID: 27040497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation by MLL fusion proteins in leukemogenesis.
    Yokoyama A
    Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCDC6, a gene product in fusion with different protoncogenes, as a potential chemotherapeutic target.
    Laxmi A; Gupta P; Gupta J
    Cancer Biomark; 2019; 24(4):383-393. PubMed ID: 30909182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.
    Duque-Afonso J; Smith KS; Cleary ML
    PLoS One; 2015; 10(11):e0143216. PubMed ID: 26588248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
    Schwarzbach MH; Koesters R; Germann A; Mechtersheimer G; Geisbill J; Winkler S; Niedergethmann M; Ridder R; Buechler MW; von Knebel Doeberitz M; Willeke F
    Oncogene; 2004 Sep; 23(40):6798-805. PubMed ID: 15286712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
    Barr FG
    Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion genes in solid tumors: the possibilities and the pitfalls.
    Barr FG
    Expert Rev Mol Diagn; 2016 Sep; 16(9):921-3. PubMed ID: 27550633
    [No Abstract]   [Full Text] [Related]  

  • 20. Next generation sequencing approach for detecting 491 fusion genes from human cancer.
    Urakami K; Shimoda Y; Ohshima K; Nagashima T; Serizawa M; Tanabe T; Saito J; Usui T; Watanabe Y; Naruoka A; Ohnami S; Ohnami S; Mochizuki T; Kusuhara M; Yamaguchi K
    Biomed Res; 2016; 37(1):51-62. PubMed ID: 26912140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.